- Home
- SUPV vs NKTR Comparison
SUPV vs NKTR Comparison
Compare SUPV & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUPV | NKTR |
|---|---|---|
| Founded | 1887 | 1990 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.1M | 860.0M |
| IPO Year | 2016 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SUPV | NKTR |
|---|---|---|
| Price | $11.43 | $43.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $13.33 | ★ $111.83 |
| AVG Volume (30 Days) | ★ 1.1M | 985.2K |
| Earning Date | 11-25-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $467,987,272.00 | $62,600,000.00 |
| Revenue This Year | $12.75 | N/A |
| Revenue Next Year | $45.23 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.54 | $6.48 |
| 52 Week High | $19.75 | $66.92 |
Technical Indicators
Market Signals| Indicator | SUPV | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 51.01 | 40.12 |
| Support Level | $11.05 | $41.51 |
| Resistance Level | $12.48 | $45.34 |
| Average True Range (ATR) | 0.63 | 2.64 |
| MACD | -0.08 | 0.09 |
| Stochastic Oscillator | 41.32 | 22.07 |
Price Performance
Historical ComparisonAbout SUPV Grupo Supervielle S.A. each Representing five Class B shares
Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, and Asset Management and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.